Investment
Features
FeesSafety
Academy
More
Pluang+

Core CPI falls faster than 1990s but hawkish Fed talk keeps rate hike fears alive

Market News
18 Sep 2026
Seeking Alpha
View Source
Bullish
Core CPI falls faster than 1990s but hawkish Fed talk keeps rate hike fears alive

Headline inflation is at 3.4% mainly due to a 16% rise in energy prices, but the "supercore" CPI excluding food, shelter, and energy remains steady near 2.0%. Core CPI has dropped from a peak of 6.6% to 2.4% faster than during the 1990s disinflation period. Despite this improvement, hawkish Federal Reserve rhetoric continues to fuel concerns about further interest rate hikes. With 30-year Treasury yields above 5%, corporate bonds and preferred stocks are trading at deep discounts driven by rising rates. Investors are advised not to fear short-term market volatility caused by rate changes but to use the higher yields to secure steady income over the next 5 to 10 years.

The story on Federal Reserve rate hikes and income opportunities is presented here with Pluang's market snapshot as of Sep 18, 2026 19:01 WIB: Of 150 priced US stocks tradable on Pluang, 59 rose and 85 fell today. Notable movers include ACN (Accenture plc) at USD 187.35 with a 1-day change of -1.55%, META (Meta Platforms Inc) at USD 692.61 with a 1-day change of +1.51% and Pluang order activity showing 74% Sell / 26% Buy, and BB (BlackBerry Limited) at USD 8.04 with a 1-day change of +1.32% and Pluang order activity 97% Sell / 3% Buy.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
Bitcoin surges past $80K as $183M in short bets liquidate, fueling a sharp price rally.

Bitcoin surges past $80K as $183M in short bets liquidate, fueling a sharp price rally.

Bitcoin's price surged from around $76,400 to nearly $81,000 on September 18, 2026, driven by a rapid liquidation of $192 million in leveraged crypto positions, including $183 million in short bets. This forced buying pushed Bitcoin above $80,000 for...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App